SEM:NYE-Select Medical Holdings Corporation (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 39.24

Change

+0.67 (+1.74)%

Market Cap

USD 1.67B

Volume

0.94M

Analyst Target

USD 22.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Select Medical Holdings Corp provides long term acute care hospital services and inpatient acute rehabilitative hospital care.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-17 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 100.33B
THC Tenet Healthcare Corporation

N/A

USD 15.77B
UHS Universal Health Services Inc

N/A

USD 15.55B
DVA DaVita HealthCare Partners Inc

N/A

USD 12.86B
EHC Encompass Health Corp

N/A

USD 9.22B
CHE Chemed Corp

N/A

USD 8.58B
NHC National HealthCare Corporatio..

N/A

USD 2.12B
AMN AMN Healthcare Services Inc

N/A

USD 2.02B
AGL agilon health Inc

N/A

USD 1.68B
BKD Brookdale Senior Living Inc

N/A

USD 1.40B

ETFs Containing SEM

QSML WisdomTree U.S. SmallCap .. 0.75 % 0.00 %

N/A

USD 1.31M
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

N/A

USD 0.20B
NUHY Nuveen ESG High Yield Cor.. 0.00 % 0.00 %

N/A

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 66.98% 91% A- 98% N/A
Dividend Return 1.06% 75% C 30% F
Total Return 68.04% 91% A- 98% N/A
Trailing 12 Months  
Capital Gain 30.28% 77% C+ 88% B+
Dividend Return 1.66% 75% C 26% F
Total Return 31.94% 77% C+ 88% B+
Trailing 5 Years  
Capital Gain 143.73% 89% A- 91% A-
Dividend Return 10.09% 100% F 38% F
Total Return 153.82% 94% A 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 19.77% 82% B 84% B
Dividend Return 21.02% 82% B 83% B
Total Return 1.25% 50% F 29% F
Risk Return Profile  
Volatility (Standard Deviation) 51.81% 32% F 17% F
Risk Adjusted Return 40.57% 82% B 62% D
Market Capitalization 1.67B 71% C- 75% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 13.50 47% 48%
Price/Book Ratio 2.80 57% 31%
Price / Cash Flow Ratio 8.38 42% 46%
Price/Free Cash Flow Ratio 10.66 39% 40%
Management Effectiveness  
Return on Equity 21.27% 71% 84%
Return on Invested Capital 9.25% 63% 63%
Return on Assets 4.80% 67% 71%
Debt to Equity Ratio 278.48% 32% 10%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.